SERA
Price
$1.94Alerts
Change
-$0.05 (-2.51%)
Updated
Nov 11 closing price
Capitalization
86.39M
133 days until earnings call
Intraday BUY SELL Signals
UTMD
Price
$73.03Alerts
Change
+$0.17 (+0.23%)
Updated
Nov 11 closing price
Capitalization
229.24M
Intraday BUY SELL Signals
Interact to see
Advertisement

SERA vs UTMD

SERA vs UTMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SERA vs. UTMD commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SERA is a Hold and UTMD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for SERA with price predictions
Nov 10, 2026

SERA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SERA turned positive on November 06, 2026. Looking at past instances where SERA's MACD turned positive, the stock continued to rise in 38 of 43 cases over the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SERA's RSI Oscillator exited the oversold zone, 24 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The 10-day moving average for SERA crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +8.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where SERA advanced for three days, in 181 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 50 cases where SERA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SERA as a result. In 83 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

SERA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SERA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

SERA broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SERA entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SERA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.455) is normal, around the industry mean (4.142). P/E Ratio (-3.318) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. SERA's P/S Ratio (1428.571) is very high in comparison to the industry average of (40.124).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SERA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for UTMD with price predictions
Nov 10, 2026

UTMD in upward trend: price may jump up because it broke its lower Bollinger Band on October 27, 2026

UTMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 39 cases where UTMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UTMD's RSI Indicator exited the oversold zone, 11 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 44%.

The Moving Average Convergence Divergence (MACD) for UTMD just turned positive on November 09, 2026. Looking at past instances where UTMD's MACD turned positive, the stock continued to rise in 33 of 51 cases over the following month. The odds of a continued upward trend are 65%.

UTMD moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTMD advanced for three days, in 137 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UTMD as a result. In 62 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The 10-day moving average for UTMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. UTMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.879) is normal, around the industry mean (4.964). P/E Ratio (22.021) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (5.980) is also within normal values, averaging (4.143). Dividend Yield (0.017) settles around the average of (0.005) among similar stocks. P/S Ratio (6.549) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
UTMD: Fundamental Ratings
UTMD
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
75
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SERAUTMD
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
44%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 3 days ago
56%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 14 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (SERA: $1.99 vs. UTMD: $72.86)
Brand notoriety: SERA and UTMD are both not notable
SERA represents the Medical/Nursing Services, while UTMD is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SERA: 178% vs. UTMD: 62%
Market capitalization -- SERA: $86.39M vs. UTMD: $229.24M
SERA [@Medical/Nursing Services] is valued at $86.39M. UTMD’s [@Pharmaceuticals: Other] market capitalization is $229.24M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SERA’s FA Score shows that 0 FA rating(s) are green while UTMD’s FA Score has 1 green FA rating(s).

  • SERA’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 1 green, 4 red.
According to our system of comparison, UTMD is a better buy in the long-term than SERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SERA’s TA Score shows that 4 TA indicator(s) are bullish while UTMD’s TA Score has 5 bullish TA indicator(s).

  • SERA’s TA Score: 4 bullish, 6 bearish.
  • UTMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, UTMD is a better buy in the short-term than SERA.

Price Growth

SERA (@Medical/Nursing Services) experienced а +3.11% price change this week, while UTMD (@Pharmaceuticals: Other) price change was +4.06% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.

Reported Earning Dates

SERA is expected to report earnings on Mar 24, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+1.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
Interact to see
Advertisement

SERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SERA has been loosely correlated with AMIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SERA jumps, then AMIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
-9.13%
AMIX - SERA
45%
Loosely correlated
+8.82%
UTMD - SERA
29%
Poorly correlated
-0.01%
NNOX - SERA
26%
Poorly correlated
+59.80%
RVTY - SERA
26%
Poorly correlated
-1.01%
MTD - SERA
26%
Poorly correlated
-0.62%
More

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
-0.01%
CERS - UTMD
50%
Loosely correlated
-5.80%
TMCI - UTMD
47%
Loosely correlated
+2.09%
INMD - UTMD
47%
Loosely correlated
-1.81%
ITGR - UTMD
44%
Loosely correlated
+0.05%
IART - UTMD
43%
Loosely correlated
+1.11%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ADPV43.250.13
+0.30%
Adaptiv Select ETF (ADPV)
VNIE24.53N/A
N/A
Vontobel International Equity Active ETF
TEMD24.15N/A
N/A
Templeton Emerging Markets Debt ETF (TEMD)
SMBS24.47-0.21
-0.85%
Schwab Mortgage-Backed Securities ETF (SMBS)
PGF12.56-0.20
-1.57%
Invesco Financial Preferred ETF (PGF)